,Set,NGenes,Direction,PValue,FDR
1,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,37,Down,3.51783304545856e-05,0.0289165876336693
2,WP_CREATINE_PATHWAY,2,Down,7.74975094411062e-05,0.0318514763802947
3,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,15,Down,0.000634468915113053,0.133132504339334
4,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,78,Down,0.00064784673644445,0.133132504339334
5,WP_SPINAL_CORD_INJURY,66,Down,0.00121550365426988,0.182116201537039
6,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.00133699222511313,0.182116201537039
7,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.00168099380625217,0.182116201537039
8,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.00177242045291522,0.182116201537039
9,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.00229177859174295,0.191839026835686
10,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.00282684203143501,0.191839026835686
11,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.00310849952614108,0.191839026835686
12,WP_ERBB_SIGNALING,69,Down,0.00332881736334343,0.191839026835686
13,WP_GPCRS_CLASS_B_SECRETINLIKE,5,Down,0.00370566014673682,0.191839026835686
14,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.00396703950170096,0.191839026835686
15,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Down,0.00399044308433471,0.191839026835686
16,WP_PROLACTIN_SIGNALING,69,Down,0.00412006200544936,0.191839026835686
17,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,9,Down,0.00413375157735007,0.191839026835686
18,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,4,Up,0.00441712797617281,0.191839026835686
19,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,23,Up,0.00447675214935733,0.191839026835686
20,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,13,Down,0.00491567773889332,0.191839026835686
21,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.00511338405190159,0.191839026835686
22,WP_GASTRIC_CANCER_NETWORK_1,18,Up,0.00541110754786615,0.191839026835686
23,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Down,0.00567269448935487,0.191839026835686
24,WP_ARYLAMINE_METABOLISM,1,Up,0.00580469873215524,0.191839026835686
25,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.0058345202808907,0.191839026835686
26,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.00610113536907017,0.19288974128368
27,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.00642552755176021,0.194793725793734
28,WP_POSTCOVID_NEUROINFLAMMATION,12,Down,0.00682478086422388,0.194793725793734
29,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.00703270715210356,0.194793725793734
30,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.00710926006546474,0.194793725793734
31,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.00789644979453003,0.203144611841989
32,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,106,Down,0.00790830605710907,0.203144611841989
33,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.0083731029851883,0.208566383449236
34,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.00952853110266125,0.230366251952575
35,WP_MAPK_CASCADE,30,Down,0.0100930709876808,0.230813892958157
36,WP_IL26_SIGNALING,31,Down,0.0103017420149942,0.230813892958157
37,WP_NETRINUNC5B_SIGNALING,35,Down,0.0103894331380193,0.230813892958157
38,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.0109930523298009,0.23779707934464
39,WP_MAPK_SIGNALING,165,Down,0.0123623496946579,0.260560293564328
40,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.0130612647475049,0.263469400357364
41,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.0131414177793819,0.263469400357364
42,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.0137204492915836,0.266849595039475
43,WP_VITAMIN_B12_METABOLISM,25,Down,0.0139592853852767,0.266849595039475
44,WP_ASPIRIN_AND_MIRNAS,8,Down,0.0146676494410505,0.274018360012352
45,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.0166975664350492,0.28276735775747
46,WP_MACROPHAGE_MARKERS,8,Down,0.0169981277563299,0.28276735775747
47,WP_BURN_WOUND_HEALING,61,Down,0.0171355161265217,0.28276735775747
48,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.0179588353100451,0.28276735775747
49,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.0185251447347086,0.28276735775747
50,WP_IRON_METABOLISM_IN_PLACENTA,8,Down,0.0191805654999785,0.28276735775747
51,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.0195066308366346,0.28276735775747
52,WP_INSULIN_SIGNALING,132,Down,0.0195423188462971,0.28276735775747
53,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.0195752901401741,0.28276735775747
54,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0199945500068709,0.28276735775747
55,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.0201698587232897,0.28276735775747
56,WP_CHEMOKINE_SIGNALING,109,Down,0.0204752468970861,0.28276735775747
57,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.0205315904503632,0.28276735775747
58,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.0205755911997646,0.28276735775747
59,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.0205924981719177,0.28276735775747
60,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.0206399531209832,0.28276735775747
61,WP_OREXIN_RECEPTOR_PATHWAY,118,Down,0.0212488308121733,0.286336703731254
62,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.0220156618933721,0.291885065747611
63,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.0226711931751232,0.295805091903988
64,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.0230633985033745,0.296220524527716
65,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.0244327993615511,0.308980939618385
66,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.0252452154013946,0.31441768272646
67,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.0261042889902579,0.315691641876956
68,WP_PROSTAGLANDIN_SIGNALING,22,Down,0.0261156102769258,0.315691641876956
69,WP_ZINC_HOMEOSTASIS,22,Up,0.026578392004986,0.316629539537659
70,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,28,Down,0.0269681591717532,0.316683240559731
71,WP_GLYOXYLATE_METABOLISM,5,Up,0.0284343128292672,0.324946312585279
72,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.0284624507373967,0.324946312585279
73,WP_GPCRS_OTHER,15,Down,0.0311037980544256,0.343533665996107
74,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.0314595979825801,0.343533665996107
75,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,24,Down,0.0320240978232378,0.343533665996107
76,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.032418228166479,0.343533665996107
77,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.0325932781895742,0.343533665996107
78,WP_PDGF_PATHWAY,37,Down,0.0325980850945211,0.343533665996107
79,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.0333915473104611,0.347441163154418
80,WP_TAMOXIFEN_METABOLISM,2,Up,0.0353685344935947,0.362274039566822
81,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Down,0.0356985367456357,0.362274039566822
82,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.0364943586359965,0.363066621816966
83,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.0368749172844221,0.363066621816966
84,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.0375043768993806,0.363066621816966
85,WP_NEURAL_CREST_DIFFERENTIATION,41,Down,0.0375895164585619,0.363066621816966
86,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.0379850723555463,0.363066621816966
87,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.039382904444658,0.366000981760037
88,WP_EGFEGFR_SIGNALING,141,Down,0.0402980108208069,0.366000981760037
89,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.0404470220318693,0.366000981760037
90,WP_GABA_RECEPTOR_SIGNALING,10,Down,0.0408973579659669,0.366000981760037
91,WP_GPR40_PATHWAY,10,Down,0.0413996187226211,0.366000981760037
92,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.0415348127003639,0.366000981760037
93,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.0419366336349809,0.366000981760037
94,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.0427096813506729,0.366000981760037
95,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Down,0.0435640824325057,0.366000981760037
96,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,20,Down,0.0438171918008803,0.366000981760037
97,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.0445581951163664,0.366000981760037
98,WP_LUNG_PATHOLOGY_OF_COVID19,15,Down,0.0447416558482301,0.366000981760037
99,WP_RANKLRANK_SIGNALING,48,Down,0.0448872691540852,0.366000981760037
100,WP_IL1_SIGNALING,54,Down,0.0449351934536706,0.366000981760037
101,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.0449709235495909,0.366000981760037
102,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.0472197681381012,0.374197937652432
103,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.0476715580316414,0.374197937652432
104,WP_FOLATE_METABOLISM,38,Down,0.0479817279408462,0.374197937652432
105,WP_DOPAMINE_METABOLISM,7,Up,0.0482182875969533,0.374197937652432
106,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.0482542352690484,0.374197937652432
107,WP_EBOLA_VIRUS_INFECTION_IN_HOST,106,Down,0.0490732773919531,0.376992841272761
108,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,38,Up,0.050681808336473,0.385744874560933
109,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.0517861501856561,0.388569893594058
110,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.0519984042522462,0.388569893594058
111,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,48,Down,0.0525053170782295,0.388823158903645
112,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.0536714083431532,0.393909800518499
113,WP_B_CELL_RECEPTOR_SIGNALING,87,Down,0.0543263245145819,0.395187953548552
114,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.0548162197754571,0.395253795223033
115,WP_RETT_SYNDROME,33,Down,0.0557507466017165,0.398496640927052
116,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.0564729676256591,0.400179132657688
117,WP_REGULATION_OF_ACTIN_CYTOSKELETON,92,Down,0.0586067920488604,0.411750282599686
118,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Down,0.0591813484212034,0.411887199336325
119,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.0599321695393085,0.411887199336325
120,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,23,Up,0.0601295181512883,0.411887199336325
121,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.061156856463027,0.413299232123686
122,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Up,0.0613412485633695,0.413299232123686
123,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.0640167636932682,0.42781934760867
124,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.0649041028673609,0.430251391588473
125,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.0658290244536772,0.432891664807382
126,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.0683951432017135,0.446196886601655
127,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.0702618196932483,0.454765478644489
128,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.0724884833211184,0.463227634776482
129,WP_MONOAMINE_TRANSPORT,12,Down,0.0726963076474041,0.463227634776482
130,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Down,0.0735356042526002,0.464971282274134
131,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,93,Down,0.0772791305468924,0.484911796256073
132,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.0792318895063359,0.493398584653092
133,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.0814965504241777,0.500371665326843
134,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Down,0.081569103593427,0.500371665326843
135,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.0847598190166119,0.51501488661103
136,WP_KIT_RECEPTOR_SIGNALING,52,Down,0.0852815586876874,0.51501488661103
137,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.0858358144351716,0.51501488661103
138,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.0865841999229311,0.515740669106155
139,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.0882083581596416,0.521635038900902
140,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.0901251645136876,0.522401459181846
141,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.0901395047728375,0.522401459181846
142,WP_ALLOGRAFT_REJECTION,51,Down,0.0908499180456571,0.522401459181846
143,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.0908800592007347,0.522401459181846
144,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.0931752906878187,0.531875617676299
145,WP_ID_SIGNALING,12,Down,0.0950255192957046,0.538696392145305
146,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.0961985889725102,0.539135774145931
147,WP_BENZENE_METABOLISM,4,Up,0.0964147917268271,0.539135774145931
148,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.100266548267972,0.55652689371649
149,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Down,0.100878962486322,0.55652689371649
150,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Down,0.101686655364562,0.557242871397798
151,WP_SYNAPTIC_VESICLE_PATHWAY,22,Down,0.10387762019617,0.56547949537253
152,WP_MEASLES_VIRUS_INFECTION,101,Up,0.106142661196266,0.574008338837702
153,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.109630959563324,0.587641945481116
154,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.110352370843512,0.587641945481116
155,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.111318254987345,0.587641945481116
156,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.111626717215992,0.587641945481116
157,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.112238181801138,0.587641945481116
158,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.115374578416508,0.599784690811428
159,WP_PHOSPHOINOSITIDES_METABOLISM,39,Down,0.11650531113465,0.599784690811428
160,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Up,0.116746411836774,0.599784690811428
161,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.117785820534354,0.600417315415344
162,WP_PLEURAL_MESOTHELIOMA,256,Down,0.120370617857265,0.600417315415344
163,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.121663666342475,0.600417315415344
164,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,49,Down,0.12183655772476,0.600417315415344
165,WP_KREBS_CYCLE_DISORDERS,12,Up,0.122084844672763,0.600417315415344
166,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.123339425379124,0.600417315415344
167,WP_METHYLATION_PATHWAYS,5,Up,0.12378094452885,0.600417315415344
168,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Up,0.123842462533763,0.600417315415344
169,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.124168648011766,0.600417315415344
170,WP_JOUBERT_SYNDROME,72,Up,0.124173897348672,0.600417315415344
171,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,13,Down,0.127631206691331,0.611696107511887
172,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.127994805951393,0.611696107511887
173,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.131176316673477,0.623277065350278
174,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,0.132592275538492,0.624149770826234
175,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,87,Down,0.132878600845001,0.624149770826234
176,WP_MELANOMA,54,Down,0.134066744909536,0.626152638157038
177,WP_GLIOBLASTOMA_SIGNALING,68,Down,0.134872953014589,0.626359137728767
178,WP_ADIPOGENESIS,86,Down,0.13577680601412,0.627014239009026
179,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.138386812108044,0.633706945441615
180,WP_NEUROINFLAMMATION,10,Down,0.138767944257288,0.633706945441615
181,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.143991797197071,0.653929598320399
182,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.144979689511701,0.654075274697489
183,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,73,Down,0.145615298381558,0.654075274697489
184,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.14838862403879,0.657198920692721
185,WP_SMALL_CELL_LUNG_CANCER,69,Down,0.14855796486804,0.657198920692721
186,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.148893402218923,0.657198920692721
187,WP_BLADDER_CANCER,29,Down,0.149947012979087,0.657198920692721
188,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Down,0.150308268966218,0.657198920692721
189,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,74,Down,0.154154335432561,0.670449014420978
190,WP_SLEEP_REGULATION,11,Up,0.156344033228906,0.672700073376423
191,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.156677846580482,0.672700073376423
192,WP_TNFALPHA_SIGNALING,85,Down,0.15798025497767,0.672700073376423
193,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.159835798526198,0.672700073376423
194,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,15,Down,0.159989458893659,0.672700073376423
195,WP_AXON_GUIDANCE,38,Down,0.160369693767126,0.672700073376423
196,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.160400504114086,0.672700073376423
197,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Up,0.1629004484845,0.677712952221172
198,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,18,Down,0.163791746846321,0.677712952221172
199,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.16418302041936,0.677712952221172
200,WP_ESTROGEN_METABOLISM_WP5276,9,Up,0.165998663189989,0.677712952221172
201,WP_G13_SIGNALING,30,Down,0.166377180804429,0.677712952221172
202,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.167159686922389,0.677712952221172
203,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Down,0.16784577797258,0.677712952221172
204,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.17005019185124,0.677712952221172
205,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.170194116456108,0.677712952221172
206,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.170546303201213,0.677712952221172
207,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.171321949202537,0.677712952221172
208,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,11,Down,0.171769513239398,0.677712952221172
209,WP_FOCAL_ADHESION,121,Down,0.177285373738797,0.677712952221172
210,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,22,Up,0.177623586660975,0.677712952221172
211,WP_HYPERTROPHY_MODEL,13,Down,0.178259564356508,0.677712952221172
212,WP_NRF2ARE_REGULATION,20,Up,0.178656035659979,0.677712952221172
213,WP_TRANSSULFURATION_PATHWAY,8,Down,0.179496830919009,0.677712952221172
214,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.179562421833688,0.677712952221172
215,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.182036852812168,0.677712952221172
216,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.182219190622201,0.677712952221172
217,WP_LUNG_FIBROSIS,33,Down,0.182767874593091,0.677712952221172
218,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.183437880583338,0.677712952221172
219,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.187856312961578,0.677712952221172
220,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.188777297589491,0.677712952221172
221,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.189724934912713,0.677712952221172
222,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.19041878729133,0.677712952221172
223,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Down,0.190419715717745,0.677712952221172
224,WP_IL18_SIGNALING,192,Down,0.190891223121226,0.677712952221172
225,WP_TAR_SYNDROME,44,Down,0.191101054663933,0.677712952221172
226,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,31,Down,0.191317139180795,0.677712952221172
227,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.193771243420399,0.677712952221172
228,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.194116788969334,0.677712952221172
229,WP_PURINE_METABOLISM,10,Down,0.194852520964656,0.677712952221172
230,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.195349036913331,0.677712952221172
231,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.195555585617076,0.677712952221172
232,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.196874382851411,0.677712952221172
233,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.198980568117772,0.677712952221172
234,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.200229515461353,0.677712952221172
235,WP_ALANINE_AND_ASPARTATE_METABOLISM,6,Up,0.200601470325472,0.677712952221172
236,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.201244551344608,0.677712952221172
237,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.201910762124167,0.677712952221172
238,WP_ENDOCHONDRAL_OSSIFICATION,26,Up,0.202314383782614,0.677712952221172
239,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Up,0.202314383782614,0.677712952221172
240,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Up,0.203146599862546,0.677712952221172
241,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.203179010431521,0.677712952221172
242,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.203818126003904,0.677712952221172
243,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.206050453391997,0.677712952221172
244,WP_TGFBETA_RECEPTOR_SIGNALING,36,Down,0.206706940529663,0.677712952221172
245,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.208325254211355,0.677712952221172
246,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.209549268289121,0.677712952221172
247,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.209579200466193,0.677712952221172
248,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,48,Down,0.2117520361204,0.677712952221172
249,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.212802239232104,0.677712952221172
250,WP_HEPATITIS_B_INFECTION,119,Down,0.21371429118932,0.677712952221172
251,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.213810343984926,0.677712952221172
252,WP_RETINOL_METABOLISM,6,Up,0.214551881259983,0.677712952221172
253,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,46,Down,0.216009771471615,0.677712952221172
254,WP_VEGFAVEGFR2_SIGNALING,344,Down,0.216328186951536,0.677712952221172
255,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.216876731921125,0.677712952221172
256,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.217147164245603,0.677712952221172
257,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.217912415676845,0.677712952221172
258,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.21896643343597,0.677712952221172
259,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.219110693448043,0.677712952221172
260,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Down,0.219887262090063,0.677712952221172
261,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,44,Down,0.220829455959332,0.677712952221172
262,WP_SERINE_METABOLISM,7,Up,0.221238100108178,0.677712952221172
263,WP_DRAVET_SYNDROME,15,Down,0.221832195638186,0.677712952221172
264,WP_NOTCH_SIGNALING_WP61,49,Down,0.222395722863584,0.677712952221172
265,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.22270141452543,0.677712952221172
266,WP_MESODERMAL_COMMITMENT_PATHWAY,77,Down,0.223015037145327,0.677712952221172
267,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,16,Up,0.223453858580172,0.677712952221172
268,WP_BDNFTRKB_SIGNALING,27,Down,0.226550412502373,0.677712952221172
269,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.226786285382519,0.677712952221172
270,WP_MONOAMINE_GPCRS,3,Up,0.226994585432884,0.677712952221172
271,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Up,0.227395109827575,0.677712952221172
272,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.227768995641688,0.677712952221172
273,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.228503321999127,0.677712952221172
274,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.229808273890062,0.677712952221172
275,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.230328309159989,0.677712952221172
276,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,47,Up,0.23037559183946,0.677712952221172
277,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.231943723916136,0.677712952221172
278,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.232656157552704,0.677712952221172
279,WP_GASTRIN_SIGNALING,94,Down,0.234493902028852,0.677712952221172
280,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Up,0.23465020827739,0.677712952221172
281,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.235698699019195,0.677712952221172
282,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.235800946002948,0.677712952221172
283,WP_OVARIAN_INFERTILITY,22,Down,0.236247086517428,0.677712952221172
284,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.236421277071703,0.677712952221172
285,WP_KININKALLIKREIN_PATHWAY,2,Up,0.237589471740829,0.677712952221172
286,WP_NOTCH_SIGNALING_WP268,35,Down,0.238099847683298,0.677712952221172
287,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.238575790388213,0.677712952221172
288,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.238864075862129,0.677712952221172
289,WP_MATRIX_METALLOPROTEINASES,8,Down,0.239681931525512,0.677712952221172
290,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.239982155002004,0.677712952221172
291,WP_NAD_METABOLISM,12,Down,0.240915198337389,0.677712952221172
292,WP_AGERAGE_PATHWAY,54,Down,0.241045386861111,0.677712952221172
293,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.241569215329444,0.677712952221172
294,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.243860555875461,0.678866521980145
295,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.243917461279183,0.678866521980145
296,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.244458017647352,0.678866521980145
297,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.247243186680605,0.68428922374228
298,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.24878179312126,0.686237026663343
299,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.250571553131562,0.687672481978996
300,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.251184373282044,0.687672481978996
301,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.252189152375688,0.687672481978996
302,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Down,0.252753877647869,0.687672481978996
303,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Down,0.25348511197036,0.687672481978996
304,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.25574030474977,0.691508324027338
305,WP_SULFATASE_AND_AROMATASE_PATHWAY,3,Up,0.256833782239188,0.692188095083974
306,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.258621273523634,0.694727734759565
307,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,5,Down,0.26087867673864,0.696923519206686
308,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,38,Down,0.261134359994719,0.696923519206686
309,WP_NUCLEAR_RECEPTORS,20,Down,0.263796106336177,0.69821349559433
310,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,169,Down,0.264365059446312,0.69821349559433
311,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.266769677642168,0.69821349559433
312,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.267656090630177,0.69821349559433
313,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.267924047824369,0.69821349559433
314,WP_OSTEOPONTIN_SIGNALING,11,Down,0.267963830698202,0.69821349559433
315,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.268260552241037,0.69821349559433
316,WP_NRF2_PATHWAY,74,Up,0.269070052877262,0.69821349559433
317,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.269262382120928,0.69821349559433
318,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.271778856103666,0.701850147407304
319,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.274016789546634,0.701850147407304
320,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.275714024206388,0.701850147407304
321,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.275803546355456,0.701850147407304
322,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.275893681374959,0.701850147407304
323,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,177,Down,0.276551533107589,0.701850147407304
324,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.276641663941565,0.701850147407304
325,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,62,Down,0.278648001346929,0.704765098791309
326,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.279612993697348,0.705036444230737
327,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.283237292842555,0.711990993017065
328,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.285570191595275,0.714869857930816
329,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.287546225277729,0.714869857930816
330,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.287912440248811,0.714869857930816
331,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,33,Down,0.289773262837916,0.714869857930816
332,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Down,0.290170741007102,0.714869857930816
333,WP_RAS_SIGNALING,119,Down,0.291312426965995,0.714869857930816
334,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.291494981492485,0.714869857930816
335,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.291494981492485,0.714869857930816
336,WP_LEPTIN_SIGNALING,70,Down,0.292209576964421,0.714869857930816
337,WP_PEPTIDE_GPCRS,14,Up,0.294504814862322,0.717965549935953
338,WP_SEROTONIN_AND_ANXIETY,8,Down,0.296663726281199,0.717965549935953
339,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.297980376042509,0.717965549935953
340,WP_ESTROGEN_METABOLISM_WP697,6,Up,0.298190795327652,0.717965549935953
341,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Down,0.298478454229201,0.717965549935953
342,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,15,Up,0.299058636477011,0.717965549935953
343,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,5,Down,0.299589031177654,0.717965549935953
344,WP_NRXN1_DELETION_SYNDROME,2,Down,0.301556320274314,0.718957289293088
345,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.30444372695666,0.718957289293088
346,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.304511021125759,0.718957289293088
347,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.305206580117872,0.718957289293088
348,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.305212215556436,0.718957289293088
349,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Down,0.3056682653325,0.718957289293088
350,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Up,0.306125366487325,0.718957289293088
351,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.308276143331767,0.721945839939352
352,WP_BLOOD_CLOTTING_CASCADE,6,Up,0.30972400469585,0.722747103348948
353,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.310376797423575,0.722747103348948
354,WP_AUTOPHAGY,27,Down,0.311499624561561,0.723312687541252
355,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.315422414458195,0.729443112876887
356,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,10,Down,0.315914535503859,0.729443112876887
357,WP_BENZOAPYRENE_METABOLISM,5,Up,0.31760919550813,0.73130184511956
358,WP_ENDOMETRIAL_CANCER,49,Down,0.319281027051393,0.733097777196215
359,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.321459303549048,0.7346523405557
360,WP_MIRNA_BIOGENESIS,6,Up,0.322714870665655,0.7346523405557
361,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.323292492469001,0.7346523405557
362,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.323783057005058,0.7346523405557
363,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,24,Down,0.324426763530072,0.7346523405557
364,WP_SILDENAFIL_TREATMENT,11,Down,0.327848806631531,0.736215898383523
365,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.328958212150659,0.736215898383523
366,WP_ENERGY_METABOLISM,41,Down,0.332961136221943,0.736215898383523
367,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.333306700831083,0.736215898383523
368,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.333978611000177,0.736215898383523
369,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.335124406630507,0.736215898383523
370,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.335644825243093,0.736215898383523
371,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.336446456831518,0.736215898383523
372,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.337246193438548,0.736215898383523
373,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,29,Up,0.337437705141097,0.736215898383523
374,WP_PURINERGIC_SIGNALING,16,Down,0.337605767318189,0.736215898383523
375,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.339690832352471,0.736215898383523
376,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.340761649586678,0.736215898383523
377,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.340889921295075,0.736215898383523
378,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.341426278580983,0.736215898383523
379,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,12,Down,0.34143366289908,0.736215898383523
380,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.341876186453364,0.736215898383523
381,WP_GLUTATHIONE_METABOLISM,11,Down,0.343560532468187,0.736215898383523
382,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.344600995445875,0.736215898383523
383,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.344603593875954,0.736215898383523
384,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.344764634302303,0.736215898383523
385,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Down,0.345425944910368,0.736215898383523
386,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.347176982234538,0.736215898383523
387,WP_COPPER_HOMEOSTASIS,40,Up,0.347502500829008,0.736215898383523
388,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,80,Down,0.348171380540662,0.736215898383523
389,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.349967781878827,0.736215898383523
390,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Down,0.351391500381575,0.736215898383523
391,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.351543122693958,0.736215898383523
392,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.351777232560492,0.736215898383523
393,WP_KLEEFSTRA_SYNDROME,25,Down,0.351986433168765,0.736215898383523
394,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.354719880608404,0.739308112342182
395,WP_CELLULAR_PROTEOSTASIS,6,Up,0.355959653220691,0.739308112342182
396,WP_GLUCURONIDATION,7,Up,0.356163032223241,0.739308112342182
397,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,33,Down,0.35844471215965,0.742170159685723
398,WP_ANGIOGENESIS,14,Down,0.360025323582864,0.743019210964
399,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Down,0.360860136765977,0.743019210964
400,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.361566526016545,0.743019210964
401,WP_MRNA_PROCESSING,124,Down,0.363166060196504,0.744445140851686
402,WP_PDGFRBETA_PATHWAY,28,Down,0.368247662825861,0.746353054160529
403,WP_NEPHROTIC_SYNDROME,27,Down,0.368562652659927,0.746353054160529
404,WP_EICOSANOID_SYNTHESIS,14,Down,0.368628554997855,0.746353054160529
405,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.370078163160082,0.746353054160529
406,WP_PPARALPHA_PATHWAY,15,Down,0.370773340293593,0.746353054160529
407,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.371568593660463,0.746353054160529
408,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,31,Down,0.372114604667016,0.746353054160529
409,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,56,Up,0.372203852506045,0.746353054160529
410,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,18,Down,0.373733550436677,0.746353054160529
411,WP_NPHP1_DELETION_SYNDROME,10,Down,0.374145909140163,0.746353054160529
412,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.374773123308154,0.746353054160529
413,WP_METABOLIC_EPILEPTIC_DISORDERS,61,Up,0.374992471250971,0.746353054160529
414,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.377248774109162,0.74903017468051
415,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.378206755911897,0.749033675708984
416,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,4,Up,0.379889446162396,0.749033675708984
417,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.381333715499795,0.749033675708984
418,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.381503662339328,0.749033675708984
419,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.381984112729648,0.749033675708984
420,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.382717936493641,0.749033675708984
421,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.38457683962033,0.749720799987365
422,WP_AMINO_ACID_METABOLISM,59,Up,0.385798334926044,0.749720799987365
423,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Down,0.385805229190578,0.749720799987365
424,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.386943783425036,0.750159882017406
425,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.388840873698373,0.752063995717794
426,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.390886551565573,0.753752914230227
427,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.391548046686505,0.753752914230227
428,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.392554501818714,0.753924767511643
429,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Up,0.396011683152139,0.755244036825494
430,WP_COMPLEMENT_AND_COAGULATION_CASCADES,25,Up,0.396041174808959,0.755244036825494
431,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,25,Up,0.396041174808959,0.755244036825494
432,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.397728272232023,0.755244036825494
433,WP_THERMOGENESIS,74,Down,0.398323323718927,0.755244036825494
434,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,137,Down,0.403832644615469,0.755244036825494
435,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.40467707228724,0.755244036825494
436,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.405676225776121,0.755244036825494
437,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.405928113093659,0.755244036825494
438,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Down,0.406640483024388,0.755244036825494
439,WP_HIPPO_SIGNALING_REGULATION,45,Down,0.406968995606323,0.755244036825494
440,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.407268293612035,0.755244036825494
441,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.407423965032869,0.755244036825494
442,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.408414404605573,0.755244036825494
443,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.408831719057974,0.755244036825494
444,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,58,Up,0.409652449085985,0.755244036825494
445,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.409950195262774,0.755244036825494
446,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.410693957828858,0.755244036825494
447,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.410698399587586,0.755244036825494
448,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Down,0.413077408428065,0.757923280642566
449,WP_OSTEOBLAST_SIGNALING,3,Down,0.415009917174196,0.759203349217966
450,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,66,Down,0.417643868635961,0.759203349217966
451,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.418585449413711,0.759203349217966
452,WP_FOXP3_IN_COVID19,9,Down,0.419071668890761,0.759203349217966
453,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,74,Down,0.419168374565611,0.759203349217966
454,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.419714928965894,0.759203349217966
455,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.420618120336715,0.759203349217966
456,WP_GPCRS_CLASS_A_RHODOPSINLIKE,43,Down,0.421347642848639,0.759203349217966
457,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.422974490081913,0.759203349217966
458,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.423064000526446,0.759203349217966
459,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.423934716899083,0.759203349217966
460,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.428136124591953,0.765060640031707
461,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.429488046165069,0.765811657153333
462,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,17,Down,0.432193720288036,0.768968047785206
463,WP_CILIOPATHIES,129,Up,0.434680392282394,0.769052979670182
464,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.434823161828439,0.769052979670182
465,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.435048218426563,0.769052979670182
466,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.438039205103621,0.772678597843726
467,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.443175409646281,0.777469867408028
468,WP_HUNGER_AND_SATIETY,2,Up,0.44491563088031,0.777469867408028
469,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,39,Down,0.445506811719077,0.777469867408028
470,WP_NONSMALL_CELL_LUNG_CANCER,60,Down,0.446803805158311,0.777469867408028
471,WP_METASTATIC_BRAIN_TUMOR,5,Down,0.447120446546586,0.777469867408028
472,WP_IDO_METABOLIC_PATHWAY,7,Down,0.447203222831064,0.777469867408028
473,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.448202847857564,0.777469867408028
474,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.449210525310218,0.777469867408028
475,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.45019911589487,0.777469867408028
476,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.450213694508785,0.777469867408028
477,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Down,0.453248224301797,0.780385465918536
478,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.453800794049952,0.780385465918536
479,WP_WNT_SIGNALING_AND_PLURIPOTENCY,61,Up,0.455247256607249,0.780623357026656
480,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.455838456657902,0.780623357026656
481,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.461009968761729,0.787838241833973
482,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.465179355293896,0.790635175143554
483,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Up,0.465502307923932,0.790635175143554
484,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.465532146921509,0.790635175143554
485,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.468066267318253,0.791667637316058
486,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.468066267318253,0.791667637316058
487,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.470738457181684,0.79455238563315
488,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.474831881053951,0.799819275053992
489,WP_UROTENSINIIMEDIATED_SIGNALING,49,Down,0.478856415352145,0.802513283520253
490,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.479245012686296,0.802513283520253
491,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.479360124341173,0.802513283520253
492,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.48121629703094,0.803983325527303
493,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Down,0.482373909526994,0.804282664566307
494,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Down,0.48505855700588,0.807121728459177
495,WP_TRANSLATION_FACTORS,49,Down,0.48782205982833,0.810080269048258
496,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.4922396975278,0.812970115803029
497,WP_PRION_DISEASE_PATHWAY,28,Down,0.492367100539304,0.812970115803029
498,WP_SELENIUM_MICRONUTRIENT_NETWORK,51,Down,0.492529340231032,0.812970115803029
499,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,19,Up,0.494459372750648,0.814520249300666
500,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.496708597149189,0.814903055560955
501,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.496933806892132,0.814903055560955
502,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.498004401377217,0.814903055560955
503,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.498657222563455,0.814903055560955
504,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.50080090798135,0.816782433255297
505,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.501998986616828,0.817115182176302
506,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.504354431898067,0.819326764862078
507,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.507534167992107,0.821880447643606
508,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.507926116061985,0.821880447643606
509,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.512226262868365,0.826872153496187
510,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.513022868957488,0.826872153496187
511,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.514740312124861,0.827542787451636
512,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.516117256164852,0.827542787451636
513,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.516465461324967,0.827542787451636
514,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Down,0.518453322934886,0.827542787451636
515,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.520452136784807,0.827542787451636
516,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.522175933982251,0.827542787451636
517,WP_CORI_CYCLE,12,Down,0.522652967361502,0.827542787451636
518,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.523732295207477,0.827542787451636
519,WP_FOXA2_PATHWAY,10,Down,0.524679777082567,0.827542787451636
520,WP_CAMKK2_PATHWAY,30,Down,0.525055257747864,0.827542787451636
521,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.525219273953882,0.827542787451636
522,WP_RAC1PAK1P38MMP2_PATHWAY,52,Down,0.5263965672904,0.827542787451636
523,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.526526615373729,0.827542787451636
524,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.527923143128891,0.828154243610589
525,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.538006607092546,0.841118236116066
526,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.53965591706298,0.841118236116066
527,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.539754585691956,0.841118236116066
528,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.540899214615133,0.841118236116066
529,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.543836949576699,0.841118236116066
530,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.544897138161524,0.841118236116066
531,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.544959352419938,0.841118236116066
532,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,63,Up,0.54527631353781,0.841118236116066
533,WP_PYRIMIDINE_METABOLISM,73,Down,0.545396617822218,0.841118236116066
534,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.547755311896644,0.843173907076857
535,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,48,Down,0.552242574469943,0.847131963286826
536,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,14,Up,0.552387752216227,0.847131963286826
537,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.555902985329082,0.849375019553759
538,WP_SMALL_LIGAND_GPCRS,7,Up,0.555916983600879,0.849375019553759
539,WP_TARGET_OF_RAPAMYCIN_SIGNALING,33,Down,0.558694733432776,0.852035381969836
540,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.561115888723779,0.852862239246925
541,WP_ENDOTHELIN_PATHWAYS,12,Down,0.56200585848895,0.852862239246925
542,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.562349554345296,0.852862239246925
543,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.566880445401114,0.855870124665851
544,WP_MALE_INFERTILITY,71,Down,0.566921504540324,0.855870124665851
545,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.568454897522087,0.855870124665851
546,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.56849767404812,0.855870124665851
547,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,25,Down,0.570618211935085,0.857287489969543
548,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.571524993313028,0.857287489969543
549,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.572607892293945,0.857347336002955
550,WP_COMPLEMENT_SYSTEM,52,Up,0.57707513310891,0.862465017119134
551,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.579470707159462,0.864473541352228
552,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.583824059998258,0.867825733520971
553,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,22,Down,0.584153535096819,0.867825733520971
554,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.586486576481452,0.867825733520971
555,WP_VITAMIN_B12_DISORDERS,9,Up,0.586704065536054,0.867825733520971
556,WP_P38_MAPK_SIGNALING,31,Down,0.586996481554331,0.867825733520971
557,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.589378256612953,0.869782633637069
558,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Down,0.591952800007116,0.870422047970164
559,WP_IL3_SIGNALING,46,Down,0.592051227529877,0.870422047970164
560,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.595047964524654,0.870422047970164
561,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.595079507248589,0.870422047970164
562,WP_IL5_SIGNALING,37,Down,0.595484299156403,0.870422047970164
563,WP_DNA_MISMATCH_REPAIR,21,Down,0.596164979327497,0.870422047970164
564,WP_HEART_DEVELOPMENT,17,Down,0.600747206016961,0.872042186551245
565,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.602601936620213,0.872042186551245
566,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Up,0.603930308020629,0.872042186551245
567,WP_DNA_REPLICATION,36,Up,0.603945526241954,0.872042186551245
568,WP_5Q35_COPY_NUMBER_VARIATION,78,Up,0.604376469124881,0.872042186551245
569,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.604761322782796,0.872042186551245
570,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.604870594337712,0.872042186551245
571,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.606463188284929,0.872042186551245
572,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.608609959361268,0.872042186551245
573,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Down,0.609672787339377,0.872042186551245
574,WP_UREA_CYCLE_AND_RELATED_DISEASES,4,Down,0.609925169916444,0.872042186551245
575,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.610872802191051,0.872042186551245
576,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.61106605772934,0.872042186551245
577,WP_CYTOSINE_METHYLATION,7,Down,0.613843330601657,0.874357449097524
578,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.614815821871495,0.874357449097524
579,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Up,0.620334802404187,0.880682569216306
580,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.622538987868842,0.881519085890157
581,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.623068842946693,0.881519085890157
582,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,12,Up,0.624910477534177,0.882605519816312
583,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.627560360589846,0.884712301802869
584,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Down,0.628554725368462,0.884712301802869
585,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.63487439493475,0.888477426816311
586,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.635568906609422,0.888477426816311
587,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.636123663158271,0.888477426816311
588,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.636726541600112,0.888477426816311
589,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.63873096863148,0.888477426816311
590,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.638769981906487,0.888477426816311
591,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.638898851914123,0.888477426816311
592,WP_G_PROTEIN_SIGNALING,62,Down,0.642991403193333,0.888477426816311
593,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.643719118680526,0.888477426816311
594,WP_WNT_SIGNALING_WP428,60,Down,0.644657786833699,0.888477426816311
595,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.646408970807734,0.888477426816311
596,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.646711382836936,0.888477426816311
597,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Down,0.647035310790618,0.888477426816311
598,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.64773989317199,0.888477426816311
599,WP_IRINOTECAN_PATHWAY,5,Up,0.64958422648422,0.888477426816311
600,WP_SPINA_BIFIDA,10,Down,0.650006115338775,0.888477426816311
601,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.651114258224445,0.888477426816311
602,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,20,Down,0.651173759611074,0.888477426816311
603,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.6535768493538,0.888477426816311
604,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,17,Up,0.654281553755617,0.888477426816311
605,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.655422101793144,0.888477426816311
606,WP_NUCLEOTIDE_GPCRS,6,Down,0.657202914854164,0.888477426816311
607,WP_ENDODERM_DIFFERENTIATION,84,Down,0.657935714705853,0.888477426816311
608,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.658152914335678,0.888477426816311
609,WP_IL2_SIGNALING,37,Down,0.659193278715249,0.888477426816311
610,WP_FERROPTOSIS,51,Down,0.659850055563581,0.888477426816311
611,WP_CHOLESTEROL_METABOLISM,54,Down,0.660413269811151,0.888477426816311
612,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.665776009333145,0.891879763188653
613,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.666743838347749,0.891879763188653
614,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.668568804193929,0.891879763188653
615,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.668759352254588,0.891879763188653
616,WP_DNA_DAMAGE_RESPONSE,58,Up,0.670211026413276,0.891879763188653
617,WP_13Q1212_COPY_NUMBER_VARIATION,20,Up,0.670415197884714,0.891879763188653
618,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Down,0.671960632476975,0.891879763188653
619,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Up,0.673013985750283,0.891879763188653
620,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.673089556191794,0.891879763188653
621,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.674945725374852,0.891879763188653
622,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.676506385293831,0.891879763188653
623,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Down,0.676673788932068,0.891879763188653
624,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.677047411471678,0.891879763188653
625,WP_FRAGILE_X_SYNDROME,84,Down,0.68001535350208,0.892805747812174
626,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.680041873992401,0.892805747812174
627,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.681443510889465,0.892805747812174
628,WP_CHOLESTASIS,9,Up,0.682094902221467,0.892805747812174
629,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.687088740060555,0.897912471112522
630,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.695435746883678,0.907378069743466
631,WP_TP53_NETWORK,16,Down,0.699122278556061,0.908125852803689
632,WP_IL17_SIGNALING,25,Down,0.700103016704031,0.908125852803689
633,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.700150999365698,0.908125852803689
634,WP_WNT_SIGNALING_WP363,38,Down,0.700427969194086,0.908125852803689
635,WP_CIRCADIAN_RHYTHM_GENES,122,Down,0.702092900856435,0.908272942696129
636,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.702751327925472,0.908272942696129
637,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.707543738076861,0.910982187912211
638,WP_BREAST_CANCER_PATHWAY,87,Down,0.708163314449272,0.910982187912211
639,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,62,Up,0.710282873198264,0.910982187912211
640,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.710949407422697,0.910982187912211
641,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Down,0.711896742883844,0.910982187912211
642,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.712004422835122,0.910982187912211
643,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,48,Up,0.714001501106887,0.910982187912211
644,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Up,0.714596897075097,0.910982187912211
645,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.715724900215259,0.910982187912211
646,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.716009832989942,0.910982187912211
647,WP_VITAMIN_D_RECEPTOR_PATHWAY,86,Down,0.717038291458882,0.910982187912211
648,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.723062120398179,0.91710912013281
649,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Down,0.726055980937847,0.91710912013281
650,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Down,0.726055980937847,0.91710912013281
651,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.727267517221709,0.91710912013281
652,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.728936581403029,0.91710912013281
653,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.730210564159737,0.91710912013281
654,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.731581260020843,0.91710912013281
655,WP_CCL18_SIGNALING,21,Down,0.731692129755926,0.91710912013281
656,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,89,Down,0.732337705602985,0.91710912013281
657,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.735008080705199,0.91710912013281
658,WP_OSTEOCLAST_SIGNALING,9,Down,0.736447874475787,0.91710912013281
659,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.737954144167882,0.91710912013281
660,WP_PI3KAKT_SIGNALING,180,Down,0.738466846147059,0.91710912013281
661,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,29,Up,0.739436911304071,0.91710912013281
662,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.739510153528229,0.91710912013281
663,WP_DISORDERS_IN_KETOLYSIS,4,Up,0.739712100545077,0.91710912013281
664,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Up,0.748148551485267,0.925477349695356
665,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.74871342767325,0.925477349695356
666,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.752357774531911,0.926829352614803
667,WP_PRIMARY_OVARIAN_INSUFFICIENCY,90,Up,0.752999190656877,0.926829352614803
668,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,93,Down,0.753189790202784,0.926829352614803
669,WP_CELL_CYCLE,96,Up,0.760545955614561,0.93026238894773
670,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,278,Down,0.760629610190303,0.93026238894773
671,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.76189416538425,0.93026238894773
672,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.762112236894951,0.93026238894773
673,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.762514745656989,0.93026238894773
674,WP_NEPHROGENESIS,4,Down,0.762899010250629,0.93026238894773
675,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.765987834393073,0.93026238894773
676,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.76608687929923,0.93026238894773
677,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.766500902496294,0.93026238894773
678,WP_INTEGRATED_CANCER_PATHWAY,41,Down,0.767296714971485,0.93026238894773
679,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,59,Up,0.770147726245362,0.931449446545717
680,WP_ACUTE_MYELOID_LEUKEMIA,56,Down,0.770542121230034,0.931449446545717
681,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,11,Up,0.772497449368767,0.932441855185208
682,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.775526436485003,0.934725411716529
683,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,16,Up,0.781320844954268,0.938753968057916
684,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,0.78220959243488,0.938753968057916
685,WP_IL4_SIGNALING,51,Down,0.782294973381597,0.938753968057916
686,WP_BASE_EXCISION_REPAIR,29,Up,0.783654652956338,0.939014759081792
687,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Up,0.786426025711369,0.940472752661996
688,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.788648946614522,0.940472752661996
689,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.789240101136653,0.940472752661996
690,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,41,Down,0.790161838081253,0.940472752661996
691,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.790592058502968,0.940472752661996
692,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.792030910820857,0.940822844934602
693,WP_HISTONE_MODIFICATIONS,37,Up,0.796274968308689,0.943339927125676
694,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Down,0.796445145286155,0.943339927125676
695,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.799647346460017,0.943947896782333
696,WP_TCELL_ACTIVATION_SARSCOV2,63,Down,0.801245859923514,0.943947896782333
697,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,9,Up,0.802052656149238,0.943947896782333
698,WP_IL11_SIGNALING,41,Up,0.802795076377191,0.943947896782333
699,WP_COMPLEMENT_ACTIVATION,12,Up,0.802956090826726,0.943947896782333
700,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.80384857390223,0.943947896782333
701,WP_ESTROGEN_SIGNALING,21,Down,0.807994748823748,0.947463171944537
702,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Down,0.811104542478776,0.948968831791139
703,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.811587699208237,0.948968831791139
704,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,126,Up,0.81497861717792,0.951580146761719
705,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Up,0.816673469127373,0.9516004690125
706,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.817311351730931,0.9516004690125
707,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.820862115400974,0.954382827241303
708,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,49,Down,0.824679190010843,0.957466517215979
709,WP_VALPROIC_ACID_PATHWAY,9,Up,0.827167043824809,0.958508449884332
710,WP_HIPPOYAP_SIGNALING,16,Down,0.828809721910178,0.958508449884332
711,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.829286561203665,0.958508449884332
712,WP_G1_TO_S_CELL_CYCLE_CONTROL,51,Up,0.830240895763558,0.958508449884332
713,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Down,0.831926035719457,0.959027285110984
714,WP_NUCLEAR_RECEPTORS_METAPATHWAY,180,Down,0.833023700205891,0.959027285110984
715,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.834243656786272,0.959088511717924
716,WP_IL6_SIGNALING,38,Down,0.836066527687807,0.959841739887399
717,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Down,0.839406731637988,0.960746151118323
718,WP_MTHFR_DEFICIENCY,18,Down,0.840357636814813,0.960746151118323
719,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.840360684494007,0.960746151118323
720,WP_SPHINGOLIPID_PATHWAY,20,Down,0.841545873433683,0.960764872170121
721,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,15,Up,0.84464121465584,0.962961273851734
722,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.846829956978909,0.963903050634971
723,WP_AFLATOXIN_B1_METABOLISM,3,Up,0.850918950550563,0.963903050634971
724,WP_IRON_METABOLISM_DISORDERS,10,Up,0.851774125732793,0.963903050634971
725,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,76,Down,0.853485176851173,0.963903050634971
726,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.854236508951498,0.963903050634971
727,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.854681000570761,0.963903050634971
728,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.855581986895957,0.963903050634971
729,WP_CANCER_PATHWAYS,311,Down,0.855666771477978,0.963903050634971
730,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.85854938367843,0.963903050634971
731,WP_HEME_BIOSYNTHESIS,8,Up,0.85854938367843,0.963903050634971
732,WP_BARDETBIEDL_SYNDROME,65,Up,0.859539981147304,0.963903050634971
733,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Up,0.860370515863978,0.963903050634971
734,WP_ATM_SIGNALING,34,Down,0.860711483170399,0.963903050634971
735,WP_ECTODERM_DIFFERENTIATION,78,Up,0.867137701827633,0.967271863923307
736,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.867354248019228,0.967271863923307
737,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,42,Down,0.868089437792785,0.967271863923307
738,WP_ONECARBON_METABOLISM,23,Down,0.868615081950208,0.967271863923307
739,WP_AEROBIC_GLYCOLYSIS,10,Up,0.870397795413992,0.967271863923307
740,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.874816350070091,0.967271863923307
741,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.875004261321709,0.967271863923307
742,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.876901006455063,0.967271863923307
743,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.87718274978509,0.967271863923307
744,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.877476922651627,0.967271863923307
745,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.879821661548391,0.967271863923307
746,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.879881206033058,0.967271863923307
747,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Up,0.879984380389439,0.967271863923307
748,WP_RETINOBLASTOMA_GENE_IN_CANCER,74,Up,0.88019386157498,0.967271863923307
749,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.884612708967979,0.969765813913342
750,WP_IL9_SIGNALING,15,Down,0.884822822913633,0.969765813913342
751,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.890640291953103,0.973958067471498
752,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.891017599438645,0.973958067471498
753,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,52,Up,0.89286097448135,0.974676920350158
754,WP_TGFB_SMAD_SIGNALING,7,Up,0.895408839094459,0.976161890896081
755,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.897066780471238,0.976674031188553
756,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,70,Down,0.90102789017252,0.978085414911847
757,WP_CYTOSOLIC_DNASENSING_PATHWAY,54,Down,0.908115566818113,0.978085414911847
758,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Up,0.908609741353277,0.978085414911847
759,WP_16P112_DISTAL_DELETION_SYNDROME,22,Up,0.910018350840576,0.978085414911847
760,WP_PPAR_SIGNALING,39,Down,0.911499033971888,0.978085414911847
761,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,13,Down,0.912433851605099,0.978085414911847
762,WP_KALLMANN_SYNDROME,11,Up,0.913898806310116,0.978085414911847
763,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,78,Down,0.917994382541343,0.978085414911847
764,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Up,0.918533845797032,0.978085414911847
765,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,4,Up,0.919975094513321,0.978085414911847
766,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.920412091415183,0.978085414911847
767,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.921137144533256,0.978085414911847
768,WP_APOPTOSIS,73,Up,0.922811769171109,0.978085414911847
769,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.923213668512488,0.978085414911847
770,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.925030607765773,0.978085414911847
771,WP_MEVALONATE_PATHWAY,7,Up,0.925060067887112,0.978085414911847
772,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.92516086400429,0.978085414911847
773,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Down,0.925734061425512,0.978085414911847
774,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,72,Down,0.928380393246325,0.978085414911847
775,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Up,0.928696972315848,0.978085414911847
776,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.929180166650593,0.978085414911847
777,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.929204926894905,0.978085414911847
778,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.93159163655625,0.978085414911847
779,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Up,0.932494208160072,0.978085414911847
780,WP_IL19_SIGNALING,20,Up,0.932542523655007,0.978085414911847
781,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,11,Up,0.93367485238758,0.978085414911847
782,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,42,Down,0.933929966971289,0.978085414911847
783,WP_STEROID_BIOSYNTHESIS,3,Down,0.933936015516741,0.978085414911847
784,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Up,0.937332269786619,0.978085414911847
785,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Down,0.937587967842075,0.978085414911847
786,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,29,Up,0.938955514756848,0.978085414911847
787,WP_4P163_COPY_NUMBER_VARIATION,22,Up,0.939075060635211,0.978085414911847
788,WP_TRYPTOPHAN_METABOLISM,18,Down,0.93951505553937,0.978085414911847
789,WP_APOPTOSIS_MODULATION_AND_SIGNALING,79,Up,0.940555437969058,0.978085414911847
790,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.942134436528419,0.978085414911847
791,WP_ALZHEIMERS_DISEASE,185,Up,0.944057661976331,0.978085414911847
792,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,185,Up,0.944057661976331,0.978085414911847
793,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.944496220985117,0.978085414911847
794,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.945306552458397,0.978085414911847
795,WP_LIPID_PARTICLES_COMPOSITION,6,Up,0.945958521721312,0.978085414911847
796,WP_ACUTE_VIRAL_MYOCARDITIS,65,Up,0.948631799798548,0.979617260595988
797,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,36,Down,0.950550316893924,0.979774699756457
798,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.95271653073638,0.979774699756457
799,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.954364640458571,0.979774699756457
800,WP_FLUOROPYRIMIDINE_ACTIVITY,26,Up,0.954738560558733,0.979774699756457
801,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.956696888332564,0.979774699756457
802,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.95898892006599,0.979774699756457
803,WP_IL7_SIGNALING,23,Down,0.959333084277225,0.979774699756457
804,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,11,Up,0.96007919001762,0.979774699756457
805,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.960313254718025,0.979774699756457
806,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.962198745421127,0.979774699756457
807,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.962466701393956,0.979774699756457
808,WP_ALSTROM_SYNDROME,27,Up,0.963087539419972,0.979774699756457
809,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.965340237730264,0.98085250360232
810,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Down,0.967530451514288,0.981864235981166
811,WP_VITAMIN_D_METABOLISM,6,Up,0.970033998078997,0.983191056006086
812,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.971963176713464,0.983933166574467
813,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.97621430235936,0.986197586601989
814,WP_ATR_SIGNALING,10,Up,0.976599556562067,0.986197586601989
815,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.980276756373028,0.988129157905999
816,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.980916536315444,0.988129157905999
817,WP_PREIMPLANTATION_EMBRYO,21,Down,0.983663013557815,0.989682983041033
818,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Up,0.988110519458659,0.99294235573963
819,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,12,Down,0.991937877307144,0.995571349385192
820,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.993804083404337,0.996227995802884
821,WP_CILIARY_LANDSCAPE,186,Up,0.998304198055014,0.998833983377491
822,WP_PROTEASOME_DEGRADATION,57,Down,0.998833983377491,0.998833983377491
